 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||| dapagliflozin/metformin (HCP1801) / Hanmi
Trial completion: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects (clinicaltrials.gov) - Jul 14, 2022
P1, N=85, Completed, Sponsor: Hanmi Pharmaceutical Company Limited
Unknown status --> Completed
- ||| dapagliflozin/metformin (HCP1801) / Hanmi
New P1 trial: A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects (clinicaltrials.gov) - Feb 1, 2019
P1, N=68, Recruiting, Sponsor: Hanmi Pharmaceutical Company Limited